Current issues highlight some of the latest research into brain tumours, new therapies becoming available and new drug treatments coming to the market.

Targeted therapy delivers toxin to glioblastoma cells

Interleukin 13 receptor is overexpressed by glioblastoma cells but minimally by normal brain cells. Aiming to exploit this difference, workers from UCSF have coupled cintredekin besudotox to IL13 and...